Characterization of FMRF amide-like immunoreactivity in rat spinal cord by region-specific antibodies in radioimmunoassay and HPLC.
Material in rat spinal cord extracts that reacts with antibodies to the molluscan tetrapeptide FMRF amide (Phe-Met-Arg-Phe-NH2) has been characterized by HPLC and radioimmunoassay using region specific antibodies. An antibody to the N-terminally extended analogue, Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2 (YGGFMRF amide), did not react with the rat material. Two antibodies to FMRF amide were characterized that differed markedly in their affinities for analogues with substitutions in the second and third positions from the C-terminus; both required the C-terminal amide, and neither showed appreciable sensitivity to substitutions in the fourth position from the C-terminus. With both antibodies the relative potency of the avian brain peptide, LPLRF amide, was about 0.1. Both antibodies revealed similar concentrations of immunoreactive material in rat spinal cord extracts. On reversed-phase HPLC using Techsil C18 and Spherisorb-phenyl columns, two peaks were separated that could be distinguished in retention times from FMRF amide, Leu-Pro-Leu-Arg-Phe-NH2 (LPLRF amide), and YGGFMRF amide. The results suggest that the rat spinal cord peptides are structurally related to the C-terminal tripeptide of FMRF amide and are probably extended at the N-terminus by sequences immunochemically distinct from other known peptides.
Dockray
G J
GJ
D000818:Animals; D000906:Antibodies / Q000276:immunology; D000918:Antibody Specificity; D002851:Chromatography, High Pressure Liquid; D000939:Epitopes / Q000276:immunology; D019835:FMRFamide; D009419:Nerve Tissue Proteins / Q000032:analysis / Q000276:immunology; D009842:Oligopeptides / Q000032:analysis* / Q000276:immunology; D011863:Radioimmunoassay; D051381:Rats; D013116:Spinal Cord / Q000032:analysis*
D000906:Antibodies; D000939:Epitopes; D009419:Nerve Tissue Proteins; D009842:Oligopeptides; D019835:FMRFamide